Table 3 The Changes in 10-years Prognostic Risk of Myocardial Infarction and Sudden Death.
| Â | Allicor | Placebo | ||||
|---|---|---|---|---|---|---|
Time | All | Men | Women | All | Men | Women |
| Â | (n = 26) | (n = 14) | (n = 12) | (n = 25) | (n = 14) | (n = 11) |
Absolute risk, % | ||||||
At the baseline | 13.1 ± 3.8 | 22.3 ± 6.0 | 2.3 ± 0.6$ | 8.9 ± 2.4 | 14.3 ± 3.7 | 2.0 ± 0.7$ |
After 12 months | 8.9 ± 2.3* | 15.1 ± 3.5* | 1.8 ± 0.6$ | 7.8 ± 2.4* | 12.4 ± 3.9* | 1.9 ± 0.6$ |
Relative risk | ||||||
At the baseline | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
After 12 months | 0.81 ± 0.08* | 0.76 ± 0.08* | 0.88 ± 0.15 | 1.05 ± 0.13 | 0.81 ± 0.10 | 1.36 ± 0.23$ |